Commonwealth Equity Services LLC Raises Stock Position in Hims & Hers Health, Inc. (NYSE:HIMS)

Commonwealth Equity Services LLC lifted its stake in Hims & Hers Health, Inc. (NYSE:HIMS) by 111.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 58,894 shares of the company’s stock after purchasing an additional 31,062 shares during the period. Commonwealth Equity Services LLC’s holdings in Hims & Hers Health were worth $1,424,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the stock. Quest Partners LLC lifted its holdings in Hims & Hers Health by 22.6% in the third quarter. Quest Partners LLC now owns 4,373 shares of the company’s stock worth $81,000 after buying an additional 807 shares during the period. Stonekeep Investments LLC lifted its stake in shares of Hims & Hers Health by 5.5% in the 4th quarter. Stonekeep Investments LLC now owns 16,952 shares of the company’s stock valued at $410,000 after purchasing an additional 882 shares during the period. Principal Securities Inc. boosted its position in shares of Hims & Hers Health by 48.2% during the fourth quarter. Principal Securities Inc. now owns 3,079 shares of the company’s stock valued at $74,000 after purchasing an additional 1,002 shares in the last quarter. Victory Capital Management Inc. grew its stake in Hims & Hers Health by 1.9% in the fourth quarter. Victory Capital Management Inc. now owns 52,579 shares of the company’s stock worth $1,271,000 after purchasing an additional 1,002 shares during the period. Finally, Cadent Capital Advisors LLC raised its holdings in Hims & Hers Health by 1.5% in the fourth quarter. Cadent Capital Advisors LLC now owns 72,160 shares of the company’s stock worth $1,745,000 after purchasing an additional 1,060 shares in the last quarter. Institutional investors own 63.52% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the stock. Bank of America boosted their target price on shares of Hims & Hers Health from $21.00 to $22.00 and gave the company an “underperform” rating in a report on Tuesday, March 18th. Piper Sandler upped their price objective on shares of Hims & Hers Health from $24.00 to $35.00 and gave the stock a “neutral” rating in a report on Tuesday, February 25th. Canaccord Genuity Group lifted their target price on shares of Hims & Hers Health from $38.00 to $68.00 and gave the company a “buy” rating in a report on Wednesday, February 19th. BTIG Research initiated coverage on Hims & Hers Health in a research note on Tuesday, January 7th. They issued a “buy” rating and a $35.00 price target on the stock. Finally, Citigroup reiterated a “sell” rating and set a $27.00 price objective on shares of Hims & Hers Health in a research note on Thursday, March 6th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $37.31.

Insiders Place Their Bets

In related news, insider Michael Chi sold 7,259 shares of the firm’s stock in a transaction on Friday, January 10th. The stock was sold at an average price of $24.07, for a total value of $174,724.13. Following the transaction, the insider now directly owns 193,601 shares of the company’s stock, valued at approximately $4,659,976.07. This trade represents a 3.61 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Soleil Boughton sold 268,932 shares of Hims & Hers Health stock in a transaction on Monday, January 6th. The shares were sold at an average price of $27.75, for a total value of $7,462,863.00. Following the transaction, the insider now owns 169,803 shares in the company, valued at $4,712,033.25. This trade represents a 61.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,061,718 shares of company stock valued at $37,894,395. Insiders own 17.71% of the company’s stock.

Hims & Hers Health Stock Down 8.8 %

Shares of NYSE HIMS opened at $29.11 on Friday. The firm’s 50-day moving average price is $39.88 and its 200-day moving average price is $29.48. Hims & Hers Health, Inc. has a 52-week low of $11.20 and a 52-week high of $72.98. The company has a market cap of $6.47 billion, a PE ratio of 66.15 and a beta of 1.37.

Hims & Hers Health (NYSE:HIMS) last posted its earnings results on Monday, February 24th. The company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. The business had revenue of $481.14 million during the quarter, compared to the consensus estimate of $494.56 million. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. As a group, equities research analysts anticipate that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.